FDA Approves NovoLog Labeling Update
Links shared publicly online about this topic.
- 1,883total visits
FDA Approves NovoLog Labeling Update
View full resource at drugs.com
Most Recently Shared on July 21, 2009 at 2:03 am By:
FDA Approves NovoLog Labeling Update - http://bit.ly/yy6w
FDA Drug Safety Communication: Important safety label changes to cholesterol-lowering statin drugs
fda.gov — “The U.S. Food and Drug Administration (FDA) has approved important safety label changes for the class of cholesterol-lowering drugs known as statins.” View full resource at fda.gov
Most Recently Shared on February 28, 2012 at 6:31 pm By:
FDA updates labeling for cholesterol pills - new warning about memory loss, no regular liver enzyme test http://t.co/lVyIGIsf #pharma
The JC Virus Antibody Test Goes Public - New Treatments - Multiple Sclerosis
healthcentral.com — “Biogen Idec was pleased to announce last week that the FDA has approved an update to the prescription labeling of their monthly IV monoclonal antibody medicatio...” View full resource at healthcentral.com
Most Recently Shared on February 3, 2012 at 9:46 pm By:
The JC Virus Antibody Test Goes Public: Biogen Idec was pleased to announce last week that th... http://t.co/9VKQqoaO via @healthcentral
National MS Society Blog: FDA updates Tysabri label to include testing for PML risk
blog.nationalmssociety.org — “Julie Stachowiak, PhD Writer, ms.about.com The US Food and Drug Administration just approv...” View full resource at blog.nationalmssociety.org
Most Recently Shared on January 24, 2012 at 9:40 pm By:
Julie Stachowiak blogs about what #FDA updates to Tysabri labels mean for people living with #MS. http://t.co/nzjftwDf
Takeda receives FDA approval for VELCADE sNDA to treat MM
news-medical.net — “Millennium: The Takeda Oncology Company with its parent company Takeda Pharmaceutical Company Limited today announced that the U.S. Food and Drug Administration (FDA) has approved a supplemental new drug application (sNDA) for VELCADE (bortezomib) for Injection, which updates the label to include additional long-term overall survival (OS) data from the VISTA trial.” View full resource at news-medical.net
Most Recently Shared on November 2, 2011 at 7:13 am By:
News-Medical.Net Oncology and Health News
Oncology News: Takeda receives FDA approval for VELCADE sNDA to treat MM: Millennium: The Takeda Oncology Compan... http://t.co/8kddwLnc
Lupron Depot-PED Labeling Updated to Include 18 Year Data - MPR
empr.com — “Abbott announced that the FDA has approved a supplemental New Drug Application (NDA) for Lupron Depot-PED (leuprolide acetate for depot suspension).” View full resource at empr.com
Most Recently Shared on October 28, 2011 at 1:23 pm By:
Lupron Depot-PED Labeling Now Includes Long-Term Data http://t.co/dR6CVHMQ #endocrinology
Osteoporosis drug labeling to include information on kidney failure
endocrinetoday.com — “The FDA has approved an update to the labeling of zoledronic acid to better inform healthcare professionals and patients of the risk for renal f” View full resource at endocrinetoday.com
Most Recently Shared on September 1, 2011 at 7:55 pm By:
#FDA: #Osteoporosis drug labeling to include information on kidney failure http://t.co/Nvc0BZ5
Pioglitazone Gets New Cancer Risk Labeling - QualityPoint Technologies
qualitypointtech.net — “(MedPage Today) -- Following a warning about bladder cancer risk, the FDA has approved updated label information for pioglitazone (Actos) and medications that contain it.” View full resource at qualitypointtech.net
Most Recently Shared on August 5, 2011 at 9:01 pm By:
Pioglitazone Gets New Cancer Risk Labeling: (MedPage Today) -- Following a warning about bladder cancer risk, the ... http://bit.ly/nUzwEf
Medical News: Pioglitazone Gets New Cancer Risk Labeling - in Endocrinology, Diabetes from MedPage Today
medpagetoday.com — “Following a warning about bladder cancer risk, the FDA has approved updated label information for pioglitazone (Actos) and medications that contain it.” View full resource at medpagetoday.com
Most Recently Shared on August 5, 2011 at 8:49 pm By:
Pioglitazone Gets New Cancer Risk Labeling http://bit.ly/rni8ws
Medical News: Pioglitazone Gets New Cancer Risk Labeling - in Endocrinology, Diabetes from MedPage Today
medpagetoday.com — “Following a warning about bladder cancer risk, the FDA has approved updated label information for pioglitazone (Actos) and medications that contain it.” View full resource at medpagetoday.com
Most Recently Shared on August 5, 2011 at 8:47 pm By:
Pioglitazone Gets New Cancer Risk Labeling http://bit.ly/rhlnZi
FDA approves labeling changes for pioglitazone due to bladder cancer risk
endocrinetoday.com — “The FDA has approve updated drug labels for pioglitazone-containing medicines to include a safety warning that the use of pioglitazone for more” View full resource at endocrinetoday.com
Most Recently Shared on August 5, 2011 at 2:21 pm By:
#FDA approves labeling changes for #pioglitazone due to bladder #cancer risk http://bit.ly/nLcLI9
Gilenya Label Updated to Include T1 Gd-Enhancing MRI Data - MPR
empr.com — “Novartis announced that the FDA has approved a supplemental New Drug Application (sNDA) for Gilenya (fingolimod capsules) that includes T1 Gd-enhancing magnetic resonance imaging (MRI) data.” View full resource at empr.com
Most Recently Shared on August 2, 2011 at 2:46 pm By:
MPR News: Gilenya Label Updated to Include T1 Gd-Enhancing MRI Data: Novartis announced that the FDA has approve... http://bit.ly/qrO1Sd
SAFETY ALERT: Chantix Labeling Updated to Include Cardiovascular Risk Data - MPR
empr.com — “The FDA has approved updated labeling for Chantix (varenicline tablets; Pfizer) to include information about the efficacy and safety of the drug in patients with cardiovascular (CV) disease and those with chronic obstructive pulmonary disease (COPD).” View full resource at empr.com
Most Recently Shared on July 25, 2011 at 2:22 pm By:
MPR News: SAFETY ALERT: Chantix Labeling Updated to Include Cardiovascular Risk Data: The FDA has approved updat... http://bit.ly/nFwqm4
Chantix (varenicline): Label Change - Risk of Certain Cardiovascular Adverse Events - Drugs.com MedNews
drugs.com — “UPDATED 07 22 2011 FDA has approved an updated drug label for Chantix (varenicline) to include information about the efficacy and safety of the drug in two pati” View full resource at drugs.com
Most Recently Shared on July 25, 2011 at 2:10 pm By:
Drugs and Devices OW OW Health
Chantix (varenicline): Label Change - Risk of Certain Cardiovascular Adverse Events: [UPDATED 07/22/2011... http://bit.ly/qNZSqU #drug
Lilly gets FDA approval for updated label for insulin - Related Stories - AAP SmartBrief
smartbrief.com — “The FDA on Wednesday granted approval to an updated label of Eli Lilly and Co.'s insulin Humalog, which now includes notice for children's use. The company also noted that, for patients with type 1 diabetes who use an insulin pump, the pump reservoir and insertion site should be changed every three…” View full resource at smartbrief.com
Most Recently Shared on June 10, 2011 at 3:25 am By:
Clara Song Doctor, Pediatrician, and Physician
Lilly gets FDA approval for updated label for insulin http://t.co/SoUwyed
FDA Approves Updates To Lilly’s Humalog® (insulin Lispro Injection [rDNA Origin]) Label | Diabetes | Type 2 Diabetes | Diabetes Mellitus | Keyvive.com
keyvive.com — “FDA Approves Updates To Lilly’s Humalog® (insulin Lispro Injection [rDNA Origin]) Label | Diabetes | Type 2 Diabetes | Diabetes Mellitus | Keyvive.com” View full resource at keyvive.com
Most Recently Shared on June 9, 2011 at 2:34 pm By:
FDA Approves Updates To Lilly’s Humalog® (insulin Lispro Injection [rDNA Origin]) Label: Eli… http://goo.gl/fb/HdrQt
Advertisement
